Acadia Pharmaceuticals says USPTO allows trofinetide dosing patent application
Expected U.S. patent term, including six months of pediatric exclusivity, runs through March 28, 2041.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.